For patients with newly diagnosed, standard-risk B-cell acute lymphoblastic leukemia (ALL) with an average or high risk for ...
Cellectis' strong cash position and pipeline updates boost confidence. See why CLLS stock could benefit from upcoming data in ...
Stay updated on promising new treatments for Diffuse Large B-cell Lymphoma and B-cell acute lymphoblastic leukemia in this ...
Brexucabtagene autoleucel showed comparable efficacy outcomes in patients aged 60 to 69 with relapsed/refractory B-cell acute ...
The Mirror US on MSN9h
Doctors diagnose 2-year-old with rare cancer after he bangs his toe on washing machineA UK mother is taking her story public after her two-year-old son was diagnosed with cancer following a toe injury that ...
The first thing 5-year-old Emily MacGillivray did after being discharged from Children's Hospital of Philadelphia on Nov. 8 was go to one of her favorite places. After nearly ...
For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an ...
The global Hematopoietic Stem Cell Transplantation Market is worth USD 7 Billion as of now and expected to reach USD 15 ...
It’s a place the Valdosta State football team is familiar with, the national semifinals. For the seventh time in program history, the Blazers find themselves a win away from play for a national title, ...
Faith, love, and applesauce. It’s those three things that Chiles High graduate Taylor Koegel said got her through her battle with Acute Lymphoblastic Leukemia. It was a summer challenge that roped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback